Henry C Nguyen

Title: Henry C Nguyen: Innovator in Immunotherapy

Introduction

Henry C Nguyen is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on IL-21 polypeptides and targeted constructs. With a total of 3 patents to his name, Nguyen is recognized for his advancements in selectively activating immune cells.

Latest Patents

Nguyen's latest patents focus on IL-21 polypeptides and targeted constructs. These patents provide methods and compositions that comprise IL-21 polypeptides, which are designed to selectively activate target immune cells, such as CD8+ T cells, over other immune cell types. Additionally, the cytokines described in these patents can include mutations that alter their charge distribution, thereby improving their half-life within the blood.

Career Highlights

Henry C Nguyen is currently associated with Asher Biotherapeutics, Inc., where he continues to push the boundaries of immunotherapy research. His work has the potential to significantly impact the treatment of various diseases by enhancing the immune response.

Collaborations

Nguyen collaborates with talented individuals in his field, including Yik Andy Yeung and Ivana Djuretic. These collaborations foster an environment of innovation and creativity, leading to groundbreaking advancements in immunotherapy.

Conclusion

Henry C Nguyen is a key figure in the field of immunotherapy, with a focus on IL-21 polypeptides and targeted constructs. His contributions are paving the way for new therapeutic approaches that could transform patient care.